Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: a retrospective controlled study
about
Is pretreatment Epstein-Barr virus DNA still associated with 6-year survival outcomes in locoregionally advanced nasopharyngeal carcinoma?Low Prognostic Nutritional Index (PNI) Predicts Unfavorable Distant Metastasis-Free Survival in Nasopharyngeal Carcinoma: A Propensity Score-Matched Analysis.Cervical nodal necrosis is an independent survival predictor in nasopharyngeal carcinoma: an observational cohort study.Recommendations for Updating T and N Staging Systems for Nasopharyngeal Carcinoma in the Era of Intensity-Modulated Radiotherapy.Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma.Radiotherapy with neoadjuvant chemotherapy versus concurrent chemoradiotherapy for ascending-type nasopharyngeal carcinoma: a retrospective comparison of toxicity and prognosis.Induction chemotherapy for the treatment of non-endemic locally advanced nasopharyngeal carcinoma.IGFBP6 is a novel nasopharyngeal carcinoma prognostic biomarker.Effects of gene polymorphisms in the endoplasmic reticulum stress pathway on clinical outcomes of chemoradiotherapy in Chinese patients with nasopharyngeal carcinoma.BST2 confers cisplatin resistance via NF-κB signaling in nasopharyngeal cancer.Intensity-modulated radiotherapy controls nasopharyngeal carcinoma distant metastasis and improves survival of patients.Effects of induction docetaxel, platinum, and fluorouracil chemotherapy in patients with stage III or IVA/B nasopharyngeal cancer treated with concurrent chemoradiation therapy: Final results of 2 parallel phase 2 clinical trials.Induction Chemotherapy Has No Prognostic Value in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma and Chronic Hepatitis B Infection in the IMRT Era.Use of pretreatment serum uric acid level to predict metastasis in locally advanced nasopharyngeal carcinoma.Promoting tumorigenesis in nasopharyngeal carcinoma, NEDD8 serves as a potential theranostic target.Propensity score matching analysis of a phase II study on simultaneous modulated accelerated radiation therapy using helical tomotherapy for nasopharyngeal carcinomas.Association between VEGF-460T/C gene polymorphism and clinical outcomes of nasopharyngeal carcinoma treated with intensity-modulated radiation therapy.DEPDC1 is required for cell cycle progression and motility in nasopharyngeal carcinoma.Cancer metastasis: issues and challengesSurvival and Toxicities of IMRT Based on the RTOG Protocols in Patients with Nasopharyngeal Carcinoma from the Endemic Regions of China.Prognostic value of nodal SUVmax of 18F-FDG PET/CT in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.Pharmacokinetic and Pharmacodynamic Analyses of 5-Fluorouracil in East-Asian Patients with Nasopharyngeal Carcinoma.Intensity-modulated radiotherapy controls nasopharyngeal carcinoma distant metastasis and improves survival of patients.Addition of chemotherapy to intensity-modulated radiotherapy does not improve survival in stage II nasopharyngeal carcinoma patients.Prognostic value of tumor burden in nasopharyngeal carcinomaInduction chemotherapy plus concurrent chemoradiotherapy versus induction chemotherapy plus volumetric modulated arc therapy alone in the treatment of stage II-IVB nasopharyngeal carcinoma patients: a retrospective controlled study
P2860
Q33702316-4EFBAD54-3370-4412-938A-26245A039674Q36072579-235EC86A-9BED-4FB5-9420-0A499E3B4867Q37397986-D9F2D41F-7AC5-40A9-BFB1-BE3002FDBB7EQ37503143-B735837D-AA09-46F6-A097-FBDF3C2BFE8DQ37526560-8DB25B31-FB7C-487F-8A2D-CECF9D0E3564Q37681958-452E9243-22D3-4081-B264-D855CC61299CQ37701674-12FB2667-0A29-4993-BBE6-6611412D0CAAQ37708763-BA78593C-0E45-4AEE-B273-0CC1BD41248EQ37744767-EB547261-A5F4-4409-8852-1C7466A53D52Q38700288-8183A78E-F63B-4504-BDA1-976574CC47A8Q38819158-884241DE-71D0-47EB-A9D5-DB266A9044E4Q38963962-0771EF49-CE40-434D-AC97-B0E048FB2BDAQ40069249-EC791C62-E37D-4399-8C6B-8C6DDCB2817BQ40416235-9B509C09-0244-49B9-B6C4-C7AFE9472304Q41083946-38A87863-22CE-4017-AFAD-3480E00463D6Q41554686-D65178E1-2D8A-4600-ADAA-6B2910078BD8Q41991817-CEF59655-A1A5-458A-942D-142D4C05D977Q42362706-3218F915-8569-400B-A68F-E7503B200F96Q42367488-2D25359F-A3B6-4538-8E82-9F103BD78AEBQ47217686-CCEA9344-1FF0-444D-B7C5-8E85CEFCE40CQ50062208-06B2E145-1831-4B17-9C34-53BA591A0DFAQ53108811-D2720BDD-6A13-4DCD-A09C-D7FF8DEEE1ACQ55044108-AFABE7C7-6DAE-4A07-B282-E9D387F3A3DBQ55259880-52E576D4-92E7-4812-8E57-A7E542978B21Q58767873-9E575F70-401C-47C4-AE65-90D177D39DB5Q58786191-9E7BE3B3-1533-434E-90C8-3E4F26F85BB0
P2860
Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: a retrospective controlled study
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Neoadjuvant chemotherapy plus ...... retrospective controlled study
@ast
Neoadjuvant chemotherapy plus ...... retrospective controlled study
@en
type
label
Neoadjuvant chemotherapy plus ...... retrospective controlled study
@ast
Neoadjuvant chemotherapy plus ...... retrospective controlled study
@en
prefLabel
Neoadjuvant chemotherapy plus ...... retrospective controlled study
@ast
Neoadjuvant chemotherapy plus ...... retrospective controlled study
@en
P2093
P2860
P921
P1476
Neoadjuvant chemotherapy plus ...... retrospective controlled study
@en
P2093
Chong Zhao
Hai-Qun Xia
Jun-Li Shi
Ka-Jia Cao
Pei-Yu Huang
Wen-Ze Qiu
P2860
P2888
P356
10.1186/S40880-015-0076-9
P577
2016-01-06T00:00:00Z
P5875
P6179
1035461788